KBC Securities - Fagron SA (FAGR) FAGRON - KBC Securities Company Note 27-6-18 - Turning the page FAGR BB

Report

KBC Securities

Lenny Van Steenhuyse

FAGRON - KBC Securities Company Note 27-6-18 - Turning the page FAGR BB

Fagron is a global leader in pharmaceutical compounding. The company has promising organic growth prospects thanks to the ramp-up of US operations. Additionally, Fagron intends to continue its buy-and-build strategy to accelerate internal growth.

27/06/2018 21 EN

Underlying

Fagron SA

Fagron supplies products, services to professionals and institutions in the healthcare sector in Europe, the U.S.A. and Brazil. Co.'s activities are subdivided into four divisions. Through Fagron, Co. offers products and concepts for pharmaceutical compounding. Through Arseus Dental, Co. supplies dental products and concepts to dentists and dental laboratories in Belgium, the Netherlands, France, Germany and Switzerland. Through Arseus Medical, Co. supplies medical and surgical products to specialists, elderly homes, homecare nurses and hospitals in Belgium and the Netherlands. Through Corilus, Co. supplies ICT total solutions for medical specialists in Belgium, the Netherlands and France.

See profile

BE0003874915 Euronext Brussels Belgium

Provider

KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

See profile

Analysts

Lenny Van Steenhuyse

Other Reports on these Companies

KBC Securities

Morning Notes : AGS BB, CMBT BB, FAGR BB, GREEN BB, SEQUA BB

: AGS BB, CMBT BB, FAGR BB, GREEN BB, SEQUA BB

April 14, 2025 April 14, 2025 1 EN

KBC Securities

Fagron Capital Markets Day feedback

Yesterday, Fagron hosted a Capital Markets Day where it laid out its strategic priorities for 2030. We see the updated Compounding for Growth strategy as a natural extension of the successful current trajectory. Financial targets are set for HSD-LDD organic CER revenue growth, a 21.0% REBITDA margin by 2027 progressively increasing thereafter to 2030, =70% operating cash conversion, =50% FCF conversion and 3.5% maintenance capex. Management continues to expect solid organic growth across all regions and business drivers and can leverage a strong balance sheet to pursue disciplined bolt-on M&A....

April 11, 2025 April 11, 2025 1 EN

GlobeNewsWire

Fagron publishes agenda for 2025 annual shareholders meeting

Fagron publishes agenda for 2025 annual shareholders meeting Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 11 April 2025 – 8 AM CET Fagron publishes agenda for 2025 annual shareholders meeting The Board of Directors of Fagron NV invites shareholders to attend Fagron’s annual general meeting of shareholders on Monday 12 May 2025. AgendaThe agenda includes the discussion of the annual report, the approval of the annual financial statements and the dividend proposal of €0.35 for the financial year 2024, and the approval of the remuneration policy. The full agenda and ...

April 11, 2025 April 11, 2025 1 EN

Aalberts 1Q25 in line with CSS – outlook uncertain

Over 1Q25 Aalberts' topline came in as expected declining 3.3% in line with the issued 1Q guidance calling for a mid single organic revenue decline. Adjusted EBITA landed at €106m (vs. our €115mE and CSS of € 108mE). Overall EBITA margin of 13.6% (vs. 14% CSS, 14.2% KBCe) was down from 14.2% in 1Q24. Gross margin was said to be at a good level, which based on historical track record should thus hover around our estimated 62-63%. Company is not formally reiterating FY25 guidance issued last February and refers to tariff and trade policy induced market uncertainty. Accumulate maintained on valua...

May 2, 2025 May 2, 2025 1 EN

Wim Lewi

Wim Lewi

Aedifica Launches a share offer on Cofinimmo after take-out speculation

Aedifica proposed a voluntary conditional exchange offer for all outstanding Cofinimmo shares. They offer 1.16 new Aedifica shares per Cofinimmo share. The offer values each Cofinimmo share at EUR 80.91, representing a 20.8% premium over Cofinimmo's “undisturbed” share price of EUR 67.00. and adjusted for the difference in proposed FY24 gross dividends. The offer is subject to a minimum acceptance threshold of 50%+1, a standstill by Cofinimmo and unconditional merger approval in Belgium, the Netherlands, and Germany, as well as FDI approval in France. The share issuance will need to be approve...

May 2, 2025 May 2, 2025 1 EN

Hilde Van Boxstael ... (+5)

Hilde Van Boxstael
Kristof Samoy
Michiel Declercq
Thomas Couvreur
Wim Lewi

Morning Notes : AALB NA, AED BB, COLR BB, INGA NA

: AALB NA, AED BB, COLR BB, INGA NA

May 2, 2025 May 2, 2025 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

FAGRON - KBC Securities Company Note 27-6-18 - Turning the page FAGR BB

We are a financial services provider for several types of professional clients, each with distinct needs.

Morning Notes : AGS BB, CMBT BB, FAGR BB, GREEN BB, SEQUA BB

Fagron Capital Markets Day feedback

Fagron publishes agenda for 2025 annual shareholders meeting

Aalberts 1Q25 in line with CSS – outlook uncertain

Aedifica Launches a share offer on Cofinimmo after take-out speculation

Morning Notes : AALB NA, AED BB, COLR BB, INGA NA

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe